Randomized clinical trial to assess the influence of treatment with ticagrelor or clopidogrel
in the number of CECs (Circulating Endothelial Cells) and EPCs (Endothelial Progenitor Cells)
in patients with ACS (Acute Coronary Syndrome), from baseline levels to chronic levels (1
month).